Literature DB >> 10225009

Psychosocial and neuropsychiatric aspects of patients with primary brain tumors.

M A Weitzner1.   

Abstract

Primary brain tumors are increasing in incidence in the United States and are devastating to patients and families. Because brain tumors and their treatment primarily affect the brain, psychiatric and psychosocial impact is rather unique. As opposed to systemic effects of other tumors and treatment, brain tumors have a direct effect on brain functioning and therefore affect cognition, mood, and personality. In fact, patients undergo dramatic changes in mood and cognition, showing specific impairments in functioning. These impairments get translated into disabilities when a patient's daily functioning is impaired and may become a handicap when viewed in the context of quality of life (QOL). This article describes observed neuropsychiatric syndromes, including the apathy syndrome, and neurocognitive effects of brain tumors and their treatment. The neuropsychiatric and neurocognitive issues are discussed in the context of QOL and psychosocial and cognitive interventions available for this patient population.

Entities:  

Mesh:

Year:  1999        PMID: 10225009     DOI: 10.3109/07357909909040599

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  29 in total

1.  7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma.

Authors:  Janine M Lupo; Cynthia F Chuang; Susan M Chang; Igor J Barani; Bert Jimenez; Christopher P Hess; Sarah J Nelson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-10-12       Impact factor: 7.038

2.  Neurocognitive functioning and quality of life in patients with recurrent malignant gliomas treated on a phase Ib trial evaluating topotecan by convection-enhanced delivery.

Authors:  Jennifer A Oberg; Amie N Dave; Jeffrey N Bruce; Stephen A Sands
Journal:  Neurooncol Pract       Date:  2014-09

3.  Facets and determinants of quality of life in patients with recurrent high grade glioma.

Authors:  A R Giovagnoli; A Silvani; E Colombo; A Boiardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

4.  Effect of Comorbid Depression on Surgical Outcomes After Craniotomy for Malignant Brain Tumors: A Nationwide Readmission Database Analysis.

Authors:  Kavelin Rumalla; Michelle Lin; Elliot Orloff; Li Ding; Gabriel Zada; William Mack; Frank Attenello
Journal:  World Neurosurg       Date:  2020-07-16       Impact factor: 2.104

5.  Meningiomatosis revealed by a major depressive syndrome.

Authors:  Sophie Dautricourt; Vincent Marzloff; Sonia Dollfus
Journal:  BMJ Case Rep       Date:  2015-12-20

6.  Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study.

Authors:  Florien W Boele; Jan J Heimans; Neil K Aaronson; Martin J B Taphoorn; Tjeerd J Postma; Jaap C Reijneveld; Martin Klein
Journal:  J Neurooncol       Date:  2013-07-04       Impact factor: 4.130

7.  Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.

Authors:  Guy Pelletier; Marja J Verhoef; Nasreen Khatri; Neil Hagen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

8.  Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments.

Authors:  Alasdair G Rooney; Shanne McNamara; Mairi Mackinnon; Mary Fraser; Roy Rampling; Alan Carson; Robin Grant
Journal:  Neuro Oncol       Date:  2012-12-09       Impact factor: 12.300

9.  The effect of brain tumour laterality on anxiety levels among neurosurgical patients.

Authors:  A Mainio; H Hakko; A Niemelä; T Tuurinkoski; J Koivukangas; P Räsänen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

10.  Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial.

Authors:  Florien W Boele; Wopke Hoeben; Karen Hilverda; Jeroen Lenting; Anne-Lucia Calis; Eefje M Sizoo; Emma H Collette; Jan J Heimans; Martin J B Taphoorn; Jaap C Reijneveld; Martin Klein
Journal:  J Neurooncol       Date:  2012-12-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.